Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat. (Q49106681)

18 February 2018

title

Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat. (English)

1 reference

18 February 2018

Tourandokht Baluchnejadmojarad

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26700436%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Zahra Kiasalari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26700436%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Mohsen Khalili

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26700436%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Mehrdad Roghani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26700436%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1

Zahra Kiasalari

1 reference

18 February 2018

author name string

Mohsen Khalili

2

1 reference

18 February 2018

Mehrdad Roghani

4

1 reference

18 February 2018

publication date

23 December 2015

1 reference

18 February 2018

published in

Neurochemical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26700436%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26700436%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26700436%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

1065-1072

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26700436%20AND%20SRC:MED&resulttype=core&format=json

Clinical approach to Parkinson's disease: features, diagnosis, and principles of management

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Parkinson's disease: an inquiry into the etiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

The emerging role of nutrition in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Hesperetin Induces Apoptosis in Breast Carcinoma by Triggering Accumulation of ROS and Activation of ASK1/JNK Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Reversal of multidrug resistance by 5,5'-dimethoxylariciresinol-4-O-β-D-glucoside in doxorubicin-resistant human leukemia K562/DOX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: an ex vivo approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Pro-cellular survival and neuroprotection of citrus flavonoid: the actions of hesperetin in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Neuroprotective effects of citrus flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Neuroprotective effects of chronic hesperetin administration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

21 January 2018

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Neuroprotective effects of hesperetin in mouse primary neurones are independent of CREB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Effect of hesperetin against oxidative stress via ER- and TrkA-mediated actions in PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Chromatographic analysis of dopamine metabolism in a Parkinsonian model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Genes, proteins, and neurotoxins involved in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Neuroprotective therapy in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Divergent roles for tumor necrosis factor-alpha in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Hesperetin protects against cardiac remodelling induced by pressure overload in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin--a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

A time-course study of behavioral and electrophysiological characteristics in a mouse model of different stages of Parkinson's disease using 6-hydroxydopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Moderate degeneration of nigral neurons after repeated but not after single intrastriatal injections of low doses of 6-hydroxydopamine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Efficacy of elevated body swing test in the early model of Parkinson's disease in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1796-6

Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions.

21 January 2018

1 reference

12 December 2020

Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes

1 reference

12 December 2020

Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects.

1 reference

12 December 2020

Antioxidative effects of hesperetin against lead acetate-induced oxidative stress in rats

1 reference

12 December 2020

Neuroprotection by scorpion venom heat resistant peptide in 6-hydroxydopamine rat model of early-stage Parkinson's disease.

1 reference

12 December 2020

Etiology and pathogenesis of Parkinson's disease

1 reference

12 December 2020

Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão), as Evaluated by a Parkinson's Disease Model in Rats

1 reference

12 December 2020

R-apomorphine protects against 6-hydroxydopamine-induced nigrostriatal damage in rat

1 reference

12 December 2020